Päivi Lehtonen starting as Injeq’s new Sales Director in April

The current CEO of Teivo, Päivi Lehtonen, will start as Injeq’s new Sales Director in the beginning of April. Päivi Lehtonen has Master’s degree in Business Administration and she has earlier worked, e.g. as a sales director at Orion Pharma Veterinary Medicines and as CEO of the pharmaceutical company Vetcare Oy and the veterinary clinic chain Univet. All these previous positions have included international sales and growth and so, Lehtonen will now take responsibility for scaling Injeq’s international business. Recruiting an international sales professional complements Injeq’s strategy of growing its medical business in key markets.

We wish Päivi warmly welcome to Injeq team.

Injeq’s distributor network is expanding outside Europe

Injeq Plc is proud to introduce Mareen Group, the new distributor of Injeq in the Kuwaiti market. Mareen group, founded […]
Read more »

Injeq introduced to health tech in Hong Kong

Injeq visited Hong Kong as part of the Finnish HealthTech delegation. There were many interesting introductions of business opportunities in […]
Read more »

Injeq enters the Czech and Slovakian market

Injeq  and S. A. B. Impex, s.r.o.  have signed a distribution agreement covering the Czech Republic and Slovakia. S.A.B. Medical […]
Read more »

Injeq participates the Congress of EPNS

          The 15th EPNS Congress will take place at the Prague Conference Centre, Prague, Czech Republic […]
Read more »

Injeq participating GNPI 2023, neonatology and pediatric intensive care congress in Hamburg in June

Germany’s 49th Annual Meeting of the Society for Neonatology and Pediatric Intensive Care Medicine will be held in Hamburg from […]
Read more »

Vingmed and Injeq signed the distribution agreement for the Norwegian market

Vingmed AS is part of the Vingmed Group, one of the largest healthcare providers in the Nordic countries in areas […]
Read more »